Press Room

Find news and updates from PhRMA, representing the country’s leading biopharmaceutical research companies. Our members are committed to finding tomorrow’s cures and treatments for some of the most serious diseases such as cancer, Alzheimer’s disease, cystic fibrosis and Parkinson’s.

Latest News from PhRMA

PhRMA CEO Statement Following Meeting With President Trump

January 31, 2017

PhRMA president and CEO Stephen J. Ubl issued the following statement after meeting with President Trump and Vice President Pence at the White House today.

Read More

PhRMA Statement Following Meeting With President Trump

January 31, 2017

This morning, we had a positive, productive meeting with President Trump, Vice President Pence and House Energy and Commerce Chairman Greg Walden, (R-Ore.). We talked about how we can work together to improve American competitiveness around the world, create more jobs here at home and enhance the U.S. biopharmaceutical industry that continues to lead the world in the development of lifesaving treatments and cures.

Read More

Medicare Monday: How Part D helps patients with heart disease live longer, healthier lives

January 30, 2017

Part D offers affordable access to medicines to help millions of beneficiaries manage heart disease.

Read More

Ask About Adherence: Q&A on appointment-based medication synchronization

January 27, 2017

American Journal of Managed Care released a study on the impact of ABMS in pharmacies for patients on medications for diabetes, hypertension & hyperlipidemia.

Read More

VIDEO: PhRMA CEO joins CNBC’s Squawk on the Street to discuss industry campaign #GOBOLDLY

January 24, 2017

PhRMA President and CEO Stephen J. Ubl talks about the biopharmaceutical industry’s new national, multi-year advertising and public affairs campaign: GOBOLDLY.

Read More

Las Compañías Biofarmacéuticas de Estados Unidos Lanzan una Innovadora Iniciativa Anunciando la Nueva Era de la Medicina

January 23, 2017

Pharmaceutical Researchers & Manufacturers of America (PhRMA) lanzó hoy una iniciativa nacional, de publicidad y asuntos públicos en nombre de las compañías biofarmacéuticas de los Estados Unidos. La campaña, GOBOLDLY, mostrará a los héroes no reconocidos de la industria, impulsando científicos y resaltando las oportunidades existentes para hacer frente a las condiciones de salud más complejas y devastadoras.

Read More

America’s Biopharmaceutical Companies Launch Groundbreaking, Multi-Year Initiative Heralding New Era of Medicine

January 23, 2017

PhRMA has launched a national, multi-year advertising and public affairs initiative on behalf of America’s biopharmaceutical companies. The campaign, GOBOLDLY, will showcase the industry’s unsung heroes driving cutting-edge advances in science and highlight the tremendous opportunity that exists to tackle our most complex and devastating health conditions.

Read More

Medicare Monday: How Medicare helps beneficiaries access needed medicines

January 23, 2017

How different groups of beneficiaries rely on Medicare to access their needed prescription medications.

Read More

New First-of-Its-Kind Study Shows Growing Share of Medicine List Prices Going to Rebates and Supply Chain

January 18, 2017

Robust competition in the private marketplace is resulting in increasingly higher rebates and discounts on medicine prices, according to a new study by the Berkeley Research Group (BRG).

Read More

Medicare Monday: A closer look at Medicare Part B

January 16, 2017

A closer look at what Medicare Part B covers and have average sales price works.

Read More